Impact BioMedical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.19 M | $545.58 K | -0.65% | 1.10% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 808.69 K | $372.00 K | 14.19% | 0.75% |
| STATE STREET CORP | 09/22/2026 | 607.90 K | $279.63 K | 0.00% | 0.56% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 589.43 K | $271.14 K | 0.72% | 0.55% |
| BLACKROCK, INC. | 08/07/2026 | 259.95 K | $119.58 K | 0.00% | 0.24% |
| NORTHERN TRUST CORP | 08/13/2026 | 235.48 K | $108.32 K | -3.47% | 0.22% |
| CITADEL ADVISORS LLC | 09/02/2026 | 49.57 K | $22.80 K | 100.00% | 0.05% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 32.20 K | $14.81 K | 0.00% | 0.03% |
| JANE STREET GROUP, LLC | 08/14/2026 | 24.53 K | $11.28 K | 100.00% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 17.19 K | $7.91 K | -54.07% | 0.02% |
| MASON & ASSOCIATES INC | 07/23/2026 | 10.00 K | $4.60 K | 0.00% | 0.01% |
| MORGAN STANLEY | 08/13/2026 | 9.29 K | $4.27 K | 0.12% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 2.40 K | $1.10 K | -92.60% | 0.00% |
| GLOBAL TRUST ASSET MANAGEMENT, LLC | 08/03/2026 | 1.82 K | $836 | 0.00% | 0.00% |
| FMR LLC | 08/13/2026 | 292 | $134 | 0.69% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 224 | $103 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 08/14/2026 | 86 | $40 | 0.00% | 0.00% |
| BURK HOLDINGS LLC | 08/13/2026 | 27 | $12 | 0.00% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 3 | $1 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
Impact BioMedical Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Impact BioMedical Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 1.19 M
VANGUARD CAPITAL MANAGEMENT LLC: 808,689
STATE STREET CORP: 607,897
VANGUARD FIDUCIARY TRUST CO: 589,428
BlackRock, Inc.: 259,946
NORTHERN TRUST CORP: 235,475
3.56% of Impact BioMedical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.65 M shares in the last 24 months. This purchase volume represents approximately $2.93 M in transactions.